Tiziana Life Sciences Ltd
Pharmaceutical Preparations
Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.
What Tiziana Life Sciences Ltd reports
Why the revenue box is blank
US GAAP has no one “total revenue” tag that every filer uses. A bank reports interest and dividend income separately from non-interest income; closed-end funds, blank-cheque companies and some property trusts report the same way; and a company that has not sold anything yet — a drug developer still in trials, for instance — files no revenue at all. Adding two differently defined income lines together would produce a number that appears in no filing, so we publish a revenue figure only where the filing tags one annual, US-dollar revenue fact we can point at. A blank here means no such tag, not that we failed to look.
Where the employee count comes from
Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.
Insiders at Tiziana Life Sciences Ltd
Shares is what each person last reported holding here.
Everyone below has filed at least one insider report against this company.
Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.
| Insider | Reported role | Shares | Value | Last action |
|---|---|---|---|---|
Gabriele M. Cerrone
|
Board Member | 44,654,830 | Not available | P Open-market purchase Jul 21, 2026 position reported |
Recent insider transactions
Of the 4 rows we hold, 2 are open-market purchases (P) and 0 open-market sales — the only codes we count as buying or selling.
The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.
A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | Gabriele M. Cerrone | P Open-market purchase | 42,357 | $0.99 | $41.9K | SEC filing ↗ |
| Jul 21, 2026 | Gabriele M. Cerrone | A Grant or award | 42,357 | $0.99 | $41.9K | SEC filing ↗ |
| Jun 12, 2026 | Gabriele M. Cerrone | P Open-market purchase | 15,000 | $1.11 | $16.7K | SEC filing ↗ |
| Jun 12, 2026 | Gabriele M. Cerrone | A Grant or award | 15,000 | $1.11 | $16.7K | SEC filing ↗ |
From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.
What a Form 4 is
The report an officer, director or large shareholder must file after trading their own company’s stock.
Subsidiaries — 3 legal entities
Subsidiaries of Tiziana Life Sciences Ltd
3 legal entities named in the subsidiary exhibit filed with this company’s most recent 20-F. . Filing on SEC.gov.
This is not the full list. SEC rules only require a company to name its significant subsidiaries.
What that leaves out
Smaller entities are left out of the exhibit entirely. A short list here means a short exhibit — it does not mean the company owns nothing else. Nothing on this page is inferred: every name below is copied from the filing.
| Subsidiary | Organised in |
|---|---|
| Longevia Genomics S.r.l. | Italy |
| Tiziana Pharma Limited | England & Wales |
| Tiziana Therapeutics Inc. | United States of America |
What counts as a subsidiary
A subsidiary is a separate legal entity this company controls; it is not the same thing as a brand, a division or an office. These entities do not file with the SEC in their own right, so there is no separate page to open for them.
Think a number here is wrong? Open the linked filing and compare — how to report it.
Sources and technical notes
Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.